HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 1 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,690,000 | -53.6% | 5,113,958 | +1.1% | 0.05% | -52.7% |
| Q2 2020 | $3,643,000 | +121.5% | 5,060,160 | 0.0% | 0.11% | +77.4% |
| Q1 2020 | $1,645,000 | -53.1% | 5,060,160 | +1.2% | 0.06% | -42.6% |
| Q4 2019 | $3,510,000 | +5.6% | 5,000,000 | 0.0% | 0.11% | -12.2% |
| Q3 2019 | $3,323,000 | – | 5,000,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 5,790,269 | $3,848,000 | 3.74% |
| PERKINS CAPITAL MANAGEMENT INC | 2,353,153 | $1,564,000 | 1.35% |
| Diametric Capital, LP | 269,822 | $179,000 | 0.15% |
| Nantahala Capital Management | 5,000,000 | $3,323,000 | 0.12% |
| Sio Capital Management, LLC | 300,000 | $199,000 | 0.06% |
| Cowen Prime Services LLC | 100,000 | $66,000 | 0.03% |
| Fondren Management LP | 40,375 | $27,000 | 0.02% |
| Kalos Management, Inc. | 66,900 | $46,000 | 0.02% |
| Alyeska Investment Group, L.P. | 1,387,665 | $922,000 | 0.01% |
| Hayden Royal, LLC | 12,000 | $8,000 | 0.01% |